What's new

Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Apr 7, 2025 - 14:07
 0
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

What Foreign Cars Will Still Be Worth It After The Tariff Price Hikes?

Next Article

Dutch supply chain manager Bleckmann opens UK facility

Related Posts

Reflection paper on use of real-world data in non-inter...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation: 30/06/2014, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Enerzair Breezhaler, indacaterol,glycopyrronium bromide,mometasone, Date of authorisation: 03/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0